Literature DB >> 20386491

Gastroschisis in mice lacking aortic carboxypeptidase-like protein is associated with a defect in neuromuscular development of the eviscerated intestine.

Enrico Danzer1, Matthew D Layne, Frederic Auber, Shincy Shegu, Portia Kreiger, Antoneta Radu, Maryann Volpe, N Scott Adzick, Alan W Flake.   

Abstract

Mice lacking aortic carboxypeptidase-like protein (ACLP) exhibit a gastroschisis (GS) like abdominal wall defect. The objectives of this study were to evaluate the pathophysiological features of GS in ACLP mice and to characterize the neuromuscular development of the eviscerated intestine (EI). ACLP mice were created by heterozygous mating from previously generated mice with targeted disruption of ACLP. Specimens were processed for H&E, and immunohistochemistry for smooth muscle cells [SMC, alpha-smooth muscle actin (alpha-SMA) antibody], interstitial cells of Cajal (ICC, c-kit-antibody), neural crest cells (NCC, Hox-b5-antibody), and enteric neurons (EN, PGP9.5-, alpha-internexin, and synaptophysin antibody). From 47 fetuses genotyped, 13 (27.7%) were wild type, 20 (42.5%) were heterozygous, and 14 (29.8%) were ACLP homozygous. In GS mice, expression of c-kit, Hox-b5, PGP-9.5, alpha-internexin, and synaptophysin were almost completely absent and only faint alpha-SMA expression was seen in the EI. In contrast, c-kit, Hox-b5, PGP9.5, alpha-internexin, synaptophysin, and alpha-SMA expression in intra-abdominal intestine in GS fetuses was the same as control intestine. The defect observed in ACLP mice closely resembles GS. Absence of ICC, NCC, EN, and immature differentiation of SMC supports an associated defect in neuromuscular development that is restricted to the EI.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20386491     DOI: 10.1203/PDR.0b013e3181e17c75

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  6 in total

Review 1.  Gastroesophageal reflux and congenital gastrointestinal malformations.

Authors:  Lucia Marseglia; Sara Manti; Gabriella D'Angelo; Eloisa Gitto; Carmelo Salpietro; Antonio Centorrino; Gianfranco Scalfari; Giuseppe Santoro; Pietro Impellizzeri; Carmelo Romeo
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

2.  Heightened Immune Activation in Fetuses with Gastroschisis May Be Blocked by Targeting IL-5.

Authors:  Michela Frascoli; Cerine Jeanty; Shannon Fleck; Patriss W Moradi; Sheila Keating; Aras N Mattis; Qizhi Tang; Tippi C MacKenzie
Journal:  J Immunol       Date:  2016-05-13       Impact factor: 5.422

Review 3.  Carboxypeptidases in disease: insights from peptidomic studies.

Authors:  Matthew R Sapio; Lloyd D Fricker
Journal:  Proteomics Clin Appl       Date:  2014-03-24       Impact factor: 3.494

4.  Dermatan sulfate epimerase 1 deficient mice as a model for human abdominal wall defects.

Authors:  Renata Gustafsson; Xanthi Stachtea; Marco Maccarana; Emma Grottling; Erik Eklund; Anders Malmström; Ake Oldberg
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-09-04

5.  Cpxm2 as a novel candidate for cardiac hypertrophy and failure in hypertension.

Authors:  Katja Grabowski; Laura Herlan; Anika Witten; Fatimunnisa Qadri; Andreas Eisenreich; Diana Lindner; Martin Schädlich; Angela Schulz; Jana Subrova; Ketaki Nitin Mhatre; Uwe Primessnig; Ralph Plehm; Sophie van Linthout; Felicitas Escher; Michael Bader; Monika Stoll; Dirk Westermann; Frank R Heinzel; Reinhold Kreutz
Journal:  Hypertens Res       Date:  2021-12-16       Impact factor: 3.872

6.  Novel exomphalos genetic mouse model: the importance of accurate phenotypic classification.

Authors:  Helen Carnaghan; Tom Roberts; Dawn Savery; Francesca C Norris; Conor J McCann; Andrew J Copp; Peter J Scambler; Mark F Lythgoe; Nicholas D Greene; Paolo Decoppi; Alan J Burns; Agustino Pierro; Simon Eaton
Journal:  J Pediatr Surg       Date:  2013-10       Impact factor: 2.545

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.